Clinical Trial Update: Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

View source ↗

Summary

An active pharmacovigilance study is being conducted to monitor the safety of Rinvoq (upadacitinib) in inflammatory diseases. Recruitment for the study is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Atopic Dermatitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: Universidade do Porto | Conditions: Inflammatory Disease, Drug Side Effect | Status: RECRUITING